Search

Reuben J Ofsaiof

from Northbrook, IL
Age ~55
Get Report
Also known as:
Ruben J Ofsaiof, Reubern Ofsaiof, Reuben S
Phone and address:
2363 Chelsea Rd APT 6-A2, Northbrook, IL 60062
(847) 840-7341
Related to:
Jerome O Burt, 87Burt J Ofsaiof, 87Rosemary Ofsaiof, 84
Connected to:
Melissa J Oftedahl, 61Peter R Oftedahl, 68Robert Oftedal, 60Lovine Ofum, 35Maria M OgaardGeorge O Ogagan, 54Anna B Ogajanova, 35Kei Ogami, 50Jay R Ogan, 66Jeree N Ogan, 83

Reuben Ofsaiof Phones & Addresses

  • 2363 Chelsea Rd APT 6-A2, Northbrook, IL 60062 (847) 840-7341
  • Gurnee, IL
  • Round Lake Park, IL
  • Waukegan, IL
  • Hammond, IN

Work

Company: Abbott 2013 Position: Senior technical support scientist

Education

Degree: Bachelors, Bachelor of Science School / High School: Purdue University Northwest 1991 to 1994 Specialities: Biology

Skills

Assay Development • Biotechnology • Dna Sequencing • Pcr • Validation • Gmp • Real Time Pcr • Gel Electrophoresis • Molecular Biology • Fda • Molecular Diagnostics • Mass Spectrometry • Lifesciences • Capa • R&D • Dna • Hplc • Glp • Multiplex Pcr • Life Sciences • Esi Ms • Ivd • Electronic Lab Notebooks • Experimental Design • Oligonucleotide Synthesis • Sample Preparation • Rt Pcr • Qpcr • Corrective and Preventive Action • U.s. Food and Drug Administration • Good Laboratory Practice • Product Support • Verification • Hepatitis B • Hepatitis C • Hiv

Industries

Pharmaceuticals

Resumes

Resumes

Reuben Ofsaiof Photo 1

Senior Technical Support Scientist

View page
Location:
2363 Chelsea Rd, Northbrook, IL 60062
Industry:
Pharmaceuticals
Work:
Abbott
Senior Technical Support Scientist
Abbott 2009 - 2012
Senior Scientist
Abbott 2002 - 2009
Scientist
Abbott 1994 - 2002
Associate Scientist
Education:
Purdue University Northwest 1991 - 1994
Bachelors, Bachelor of Science, Biology Wabash College 1987 - 1991
Bachelors, Bachelor of Arts, Art
Skills:
Assay Development
Biotechnology
Dna Sequencing
Pcr
Validation
Gmp
Real Time Pcr
Gel Electrophoresis
Molecular Biology
Fda
Molecular Diagnostics
Mass Spectrometry
Lifesciences
Capa
R&D
Dna
Hplc
Glp
Multiplex Pcr
Life Sciences
Esi Ms
Ivd
Electronic Lab Notebooks
Experimental Design
Oligonucleotide Synthesis
Sample Preparation
Rt Pcr
Qpcr
Corrective and Preventive Action
U.s. Food and Drug Administration
Good Laboratory Practice
Product Support
Verification
Hepatitis B
Hepatitis C
Hiv

Publications

Us Patents

Hepatitis B Virus Typing And Resistance Assay

View page
US Patent:
20130252232, Sep 26, 2013
Filed:
Feb 22, 2013
Appl. No.:
13/774960
Inventors:
Reuben J. Ofsaiof - Des Plaines IL, US
Roy M. Vijesurier - Des Plaines IL, US
Hong Wang - Des Plaines IL, US
Assignee:
ABBOTT MOLECULAR INC. - Des Plaines IL
International Classification:
C12Q 1/70
US Classification:
435 5
Abstract:
The present invention provides methods, kits, and oligonucleotides for detecting and analyzing the nucleotide sequence of a reverse transcriptase (RT) region of the polymerase (Pol) gene of Hepatitis B Virus (HBV). In certain embodiments, a target RT region is amplified and subjected to DNA sequencing. The sequence obtained is compared to one or more DNA sequences characteristic of an HBV genotype or serotype, and/or one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine, to determine the HBV genotype or serotype of the amplified product and/or the presence or absence of one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine.

Hepatitis B Virus Typing And Resistance Assay

View page
US Patent:
20150259755, Sep 17, 2015
Filed:
Apr 30, 2015
Appl. No.:
14/701368
Inventors:
- Des Plaines IL, US
Reuben J. Ofsaiof - Des Plaines IL, US
Roy M. Vijesurier - Des Plaines IL, US
Hong Wang - Des Plaines IL, US
International Classification:
C12Q 1/70
Abstract:
The present invention provides methods, kits, and oligonucleotides for detecting and analyzing the nucleotide sequence of a reverse transcriptase (RT) region of the polymerase (Pol) gene of Hepatitis B Virus (HBV). In certain embodiments, a target RT region is amplified and subjected to DNA sequencing. The sequence obtained is compared to one or more DNA sequences characteristic of an HBV genotype or serotype, and/or one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine, to determine the HBV genotype or serotype of the amplified product and/or the presence or absence of one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine.
Control profile
Reuben J Ofsaiof from Northbrook, IL, age ~55 Get Report